Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2015-03-03 Regulatory Filings
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a letter from legal counsel submitting a draft Registration Statement on Form S-1 confidentially to the SEC under the JOBS Act. It references the confidential submission of a registration statement for review prior to public filing. The document is short (3164 characters) and is a cover letter for a draft registration statement, not the registration statement itself or a financial report. This fits the description of a Regulatory Filing (RNS) as it is a regulatory submission and does not contain financial data or report content itself.
2015-03-03 English
Capital/Financing Update 2015
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC by Collegium Pharmaceutical, Inc. It is a preliminary prospectus for an initial public offering (IPO) of common stock. The text includes details about the offering, underwriting, risk factors, and other typical IPO prospectus sections. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory filing of a different nature. It is a registration statement related to capital raising and securities offering. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief summary, so it is not RPA or FS. Hence, the classification is CAP with high confidence.
2015-03-03 English
Regulatory Filings 2013
Regulatory Filings
2013-10-02 English
Regulatory Filings 2012
Regulatory Filings
2012-02-24 English
Regulatory Filings 2010
Regulatory Filings
2010-03-08 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2008-07-03 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.